Citation Impact
8 standout
Citing Papers
Aging and cancer
2024 Standout
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
2022 Standout
Works of Eike Simon being referenced
A randomized phase 2 study comparing EC or CMF versus nab‐paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high‐risk early breast cancer (ICE II‐GBG 52)
2015
Author Peers
| Author | Oncology | Molecular Biology | PPCH | Cancer Research | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Eike Simon | 44 | 1 | 12 | 40 | 4 | 62 | |
| Katarina Pettersson | 749 | 1513 | 48 | 300 | 28 | 3.9k | |
| Yongbok Kim | 47 | 7 | 121 | 39 | 683 | ||
| Lingying Wen | 19 | 166 | 12 | 13 | 442 | ||
| Hiroyuki Nakaoka | 23 | 188 | |||||
| G. D. Killam | 12 | 216 |
All Works
Loading papers...